Podcast
Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.
In this week’s episode, we spoke with Matt Gibbs, president of Capital Rx, to discuss alternative career paths in independently owned PBMs.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria